Evolution of the Average Target: IRADIMED CORPORATION

Evolution of the Target Price: IRADIMED CORPORATION

Changes in Analyst Recommendations: IRADIMED CORPORATION

5f2ea99fd14037cfc.cCVnPeL5lsdvFqQP7KfRpId_RHHKn3gS3VR37qaBvHQ.GXECfJbUprQoV8ZbgMqikshOPjy8pisnpG0tj-y1yztAcgJukoHytDgunA~52743e7f0a8e41d9f402cc29193c7297

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +27.57%
+46.89%
+27.2%
+55.63%
- - +40.85%
Average +39.63%
Weighted average by Cap. +42.03%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
90.27USD
Average target price
118.00USD
Spread / Average Target
+30.72%
High Price Target
120.00USD
Spread / Highest target
+32.93%
Low Price Target
116.00USD
Spread / Lowest Target
+28.50%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Roth Capital Partners
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
90.27USD
Average target price
118.00USD
Spread / Average Target
+30.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION